Stock Scorecard
Stock Summary for GSK Plc (GSK) - $43.72 as of 10/3/2025 4:07:24 PM EST
Total Score
11 out of 30
Safety Score
51 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GSK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GSK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GSK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GSK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GSK (51 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for GSK
Financial Details for GSK
Company Overview |
|
|---|---|
| Ticker | GSK |
| Company Name | GSK Plc |
| Country | USA |
| Description | GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of innovative pharmaceuticals, vaccines, and consumer healthcare products. Headquartered in Brentford, UK, GSK operates with a mission to enhance the quality of human health by addressing the world's health challenges through its diverse product portfolio. With a strong emphasis on research and development, GSK is committed to delivering effective treatments across various therapeutic areas, positioning itself as a key player in the global healthcare ecosystem. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/29/2025 |
Stock Price History |
|
| Last Day Price | 43.72 |
| Price 4 Years Ago | 47.19 |
| Last Day Price Updated | 10/3/2025 4:07:24 PM EST |
| Last Day Volume | 13,114,846 |
| Average Daily Volume | 4,494,270 |
| 52-Week High | 45.59 |
| 52-Week Low | 30.68 |
| Last Price to 52 Week Low | 42.50% |
Valuation Measures |
|
| Trailing PE | 19.68 |
| Industry PE | 26.58 |
| Sector PE | 41.81 |
| 5-Year Average PE | 11.07 |
| Free Cash Flow Ratio | 24.42 |
| Industry Free Cash Flow Ratio | 38.57 |
| Sector Free Cash Flow Ratio | 30.43 |
| Current Ratio Most Recent Quarter | 0.87 |
| Total Cash Per Share | 1.79 |
| Book Value Per Share Most Recent Quarter | 3.66 |
| Price to Book Ratio | 4.42 |
| Industry Price to Book Ratio | 10.68 |
| Sector Price to Book Ratio | 32.30 |
| Price to Sales Ratio Twelve Trailing Months | 2.86 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.95 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.26 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 2,012,288,000 |
| Market Capitalization | 87,977,231,360 |
| Institutional Ownership | 19.09% |
Dividends |
|
| Ex-Dividend Date | 8/15/2025 |
| Previous Dividend Amount | 0.4348 |
| Current Dividend Amount | 0.4281 |
| Total Years Dividend Increasing | 1 |
| Trailing Annual Dividend Rate | 1.65 |
| Trailing Annual Dividend Yield | 3.77% |
| Forward Annual Dividend Rate | 1.71 |
| Forward Annual Dividend Yield | 3.92% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 4.76% |
| 5-Year Average Dividend Yield | 5.17% |
| 1-Year Dividend Growth Rate Percentage | 9.85% |
| 3-Year Dividend Growth Rate Percentage | 4.81% |
| 5-Year Dividend Growth Rate Percentage | -11.14% |
| All-Time Dividend Growth Rate Percentage | 0.33% |
| Dividend Payout Ratio | 74.21% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 23.20% |
| Annual Earnings Growth | -47.75% |
| Reported EPS 12 Trailing Months | 2.22 |
| Reported EPS Past Year | 2.44 |
| Reported EPS Prior Year | 4.06 |
| Net Income Twelve Trailing Months | 3,423,000,000 |
| Net Income Past Year | 2,575,000,000 |
| Net Income Prior Year | 4,928,000,000 |
| Quarterly Revenue Growth YOY | 1.30% |
| 5-Year Revenue Growth | -1.45% |
| Operating Margin Twelve Trailing Months | 30.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,599,000,000 |
| Total Cash Past Year | 3,693,000,000 |
| Total Cash Prior Year | 2,746,000,000 |
| Net Cash Position Most Recent Quarter | -11,705,000,000 |
| Net Cash Position Past Year | -10,010,000,000 |
| Long Term Debt Past Year | 13,703,000,000 |
| Long Term Debt Prior Year | 14,154,000,000 |
| Total Debt Most Recent Quarter | 15,304,000,000 |
| Equity to Debt Ratio Past Year | 0.50 |
| Equity to Debt Ratio Most Recent Quarter | 0.49 |
| Total Stockholder Equity Past Year | 13,671,000,000 |
| Total Stockholder Equity Prior Year | 13,347,000,000 |
| Total Stockholder Equity Most Recent Quarter | 14,791,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 4,666,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.32 |
| Free Cash Flow Past Year | 3,572,000,000 |
| Free Cash Flow Prior Year | 4,424,000,000 |
Options |
|
| Put/Call Ratio | 0.32 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.29 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/4/2025 12:49:10 AM EST |